Welcome to our dedicated page for Enovix Corporation SEC filings (Ticker: ENVX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Enovix Corporation (ENVX) SEC filings page on Stock Titan provides access to the company’s official U.S. regulatory documents, along with AI-powered summaries to help interpret complex disclosures. As a Nasdaq-listed battery technology company focused on advanced lithium-ion cells and 100% active silicon-anode architectures, Enovix uses its SEC reports to describe financial performance, capital structure, risk factors and material events.
Through this page, you can review annual reports on Form 10-K and quarterly reports on Form 10-Q, which discuss Enovix’s business model, battery technology, manufacturing footprint in regions such as Malaysia and South Korea, and markets including smartphones, smart eyewear, IoT, industrial and defense applications. Our AI tools highlight key sections, such as revenue trends, operating expenses, liquidity, and the Risk Factors and MD&A discussions referenced in the company’s press releases.
You can also follow current reports on Form 8-K, where Enovix has disclosed items such as quarterly financial results, a warrant dividend distribution, authorization of a share repurchase plan, and the issuance of 4.75% Convertible Senior Notes due 2030 with related capped call transactions. These filings explain terms of the notes, conversion conditions, redemption provisions and the intended use of proceeds, including potential acquisitions in the battery ecosystem.
In addition, this page surfaces registration statements, prospectus supplements and related exhibits that describe the warrant program (ENVXW), share issuance mechanics and legal opinions, as well as any future Form 4 insider transaction reports when available. AI-generated overviews help clarify technical language, summarize covenant and event-of-default provisions, and point out changes in capital structure or share count. Together, these tools allow investors to navigate Enovix’s regulatory history more efficiently while still relying on the underlying SEC documents as the authoritative source.
Enovix Corp Chief Accounting Officer Kristina Truong reported acquiring common stock through the vesting of performance restricted stock units (PRSUs) after performance criteria were achieved on February 18, 2026. Awards covering 24,116 PRSUs and 11,162 PRSUs vested at a price of $0.00 per share.
The 24,116 vested PRSUs will be released in two equal installments on April 1, 2027 and April 1, 2028, and the 11,162 vested PRSUs will be released in two equal installments on April 8, 2027 and April 8, 2028. Each PRSU represents a contingent right to receive one share of Enovix common stock upon settlement.
Enovix Corp Chief Legal Officer Arthi Chakravarthy reported an acquisition of common stock through the vesting of performance-based equity awards. On February 18, 2026, 36,174 performance restricted stock units (PRSUs) vested upon achievement of performance criteria, with 50% scheduled for release on April 1, 2027 and the remaining 50% on April 1, 2028.
On the same date, an additional 22,326 PRSUs vested, with 50% to be released on April 8, 2027 and 50% on April 8, 2028. Each PRSU represents a contingent right to receive one share of Enovix common stock upon settlement. Following these transactions, Chakravarthy directly owned 458,097 shares, including 262,360 shares issuable upon vesting and settlement of RSUs and previously vested PRSUs.
Talluri Rajendra K reported acquisition or exercise transactions in this Form 4 filing.
Enovix Corp President and CEO Rajendra K. Talluri reported awards of common stock tied to performance-based restricted stock units. On February 18, 2026, 168,813 PRSUs vested after meeting performance criteria; 50% will be released on April 1, 2027 and 50% on April 1, 2028.
On the same date, 90,798 additional PRSUs vested, with 50% scheduled for release on April 8, 2027 and the remainder on April 8, 2028. Reported direct holdings include shares plus 1,446,958 shares issuable upon vesting and settlement of RSUs and vested PRSUs, including 47,775 PRSUs to be released on March 2, 2027.
Enovix Corp Chief Accounting Officer Kristina Truong reported a tax-withholding share disposition. On March 2, 2026, 1,260 shares of common stock were withheld at $5.45 per share to satisfy tax obligations tied to vested performance restricted stock units.
After this transaction, she directly owns 190,289 shares, including 137,235 shares issuable upon vesting and settlement of restricted stock units and 2,489 vested performance RSUs scheduled for release on March 2, 2027.
Enovix President and CEO Rajendra K. Talluri reported a tax-related share disposition on common stock. On March 2, 2026, 24,175 shares were withheld at
Enovix Corp Chief Legal Officer reports tax-related share withholding. Arthi Chakravarthy disposed of 5,259 shares of Enovix common stock on March 2, 2026 at
Enovix Corp Chief Legal Officer Arthi Chakravarthy reported a tax-withholding disposition of 2,221 shares of common stock on February 24, 2026, at $6.11 per share, to cover taxes on vested RSUs. Following this, she holds 404,856 shares, including unvested RSUs and performance RSUs with future release dates.
Enovix Corporation filed Amendment No. 1 to its Annual Report for the year ended December 28, 2025 to replace the consent of Deloitte & Touche LLP. The new consent now includes references to Enovix’s effective Registration Statements on Form S-3 (Nos. 333-275524, 333-273858, and 333-281260).
The amendment also files updated certifications from the principal executive officer and principal financial officer under Rules 13a-14(a) and 15d-14(a. It does not modify any financial statements or other disclosures in the original report and does not reflect events occurring after the original filing.
Enovix Corporation is a global battery company focused on designing, developing, manufacturing and commercializing advanced lithium-ion batteries using a proprietary 100% active silicon-anode architecture. Its AI-1™ platform targets smartphones, smart eyewear, defense, industrial and emerging edge-AI devices that require higher energy density in tight spaces.
The company has shifted from a broad, standard-cell strategy to deeper vertical programs with a smaller set of large OEM and ODM customers. Manufacturing has been consolidated into Fab2 in Malaysia and facilities in South Korea, supported by R&D centers in India and the U.S. A recent independent test showed the AI-1™ smartphone battery reached 935 Wh/L volumetric energy density.
Enovix highlights substantial risks: scaling a new and complex manufacturing process, achieving targeted throughput and yields, controlling raw material and production costs, and maintaining key third‑party manufacturing and supply relationships. It also notes a history of losses, a need for additional capital, customer concentration in certain sectors, global trade and geopolitical exposure, and the possibility that products under development may not reach commercial scale or expected performance.
Enovix Corporation reported strong top-line growth but continued losses, and expanded its share repurchase capacity. For full year 2025, revenue rose to
The company still posted a 2025 GAAP net loss of